Citadel Advisors’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
24,600
+13,400
+120% +$880K ﹤0.01% 6995
2025
Q4
$688K Sell
11,200
-11,300
-50% -$730K ﹤0.01% 8244
2025
Q3
$1.64M Buy
22,500
+14,700
+188% +$1.16M ﹤0.01% 6473
2025
Q2
$580K Buy
7,800
+2,100
+37% +$147K ﹤0.01% 8300
2025
Q1
$427K Sell
5,700
-200
-3% -$18.6K ﹤0.01% 8827
2024
Q4
$603K Sell
5,900
-11,100
-65% -$1.27M ﹤0.01% 8151
2024
Q3
$1.79M Buy
17,000
+2,400
+16% +$245K ﹤0.01% 5743
2024
Q2
$1.36M Sell
14,600
-4,300
-23% -$456K ﹤0.01% 6034
2024
Q1
$2.46M Sell
18,900
-9,300
-33% -$1.09M ﹤0.01% 5119
2023
Q4
$3.2M Buy
28,200
+6,300
+29% +$546K ﹤0.01% 4528
2023
Q3
$1.8M Sell
21,900
-10,400
-32% -$914K ﹤0.01% 5415
2023
Q2
$3.03M Buy
32,300
+1,400
+5% +$112K ﹤0.01% 4455
2023
Q1
$2.1M Sell
30,900
-36,700
-54% -$2.97M ﹤0.01% 5270
2022
Q4
$4.81M Buy
67,600
+1,800
+3% +$123K ﹤0.01% 3931
2022
Q3
$4.09M Buy
65,800
+11,600
+21% +$836K ﹤0.01% 4210
2022
Q2
$3.62M Buy
54,200
+11,800
+28% +$887K ﹤0.01% 4413
2022
Q1
$3.05M Buy
42,400
+600
+1% +$49.1K ﹤0.01% 5139
2021
Q4
$4M Sell
41,800
-20,600
-33% -$1.39M ﹤0.01% 4746
2021
Q3
$3.05M Buy
62,400
+12,200
+24% +$613K ﹤0.01% 5329
2021
Q2
$2.52M Buy
50,200
+27,800
+124% +$1.37M ﹤0.01% 6017
2021
Q1
$878K Sell
22,400
-47,600
-68% -$1.85M ﹤0.01% 8422
2020
Q4
$2.05M Buy
70,000
+33,800
+93% +$864K ﹤0.01% 5308
2020
Q3
$779K Buy
+36,200
New +$584K ﹤0.01% 6483
2020
Q2
Sell
-38,500
Closed -$191K 9801
2020
Q1
$191K Sell
38,500
-2,800
-7% -$31.5K ﹤0.01% 8055
2019
Q4
$589K Buy
41,300
+31,000
+301% +$636K ﹤0.01% 6556
2019
Q3
$333K Sell
10,300
-6,000
-37% -$151K ﹤0.01% 7410
2019
Q2
$323K Buy
16,300
+1,100
+7% +$25.1K ﹤0.01% 7465
2019
Q1
$405K Buy
15,200
+5,000
+49% +$142K ﹤0.01% 7137
2018
Q4
$252K Buy
+10,200
New +$250K ﹤0.01% 7531
2018
Q3
Sell
-6,100
Closed -$229K 9219
2018
Q2
$229K Buy
+6,100
New +$238K ﹤0.01% 7655

Other funds holding BXC

Citadel Advisors's BXC Position: Q1 2026 in Review

Citadel Advisors increased its BlueLinx (BXC) stake by 54% in Q1 2026, buying an estimated $629K and bringing the position to 27,395 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #6734.

Citadel Advisors first reported a position in BXC in Q4 2013 and has held it in 30 quarters since. The position peaked at $8.18M in Q4 2023. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • Citadel Advisors held 27,395 shares of BlueLinx worth $1.48M as of Q1 2026.
  • Citadel Advisors bought 9,580 BlueLinx shares in Q1 2026, an estimated $629K.
  • BlueLinx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6734 holding.
  • Citadel Advisors first reported a position in BlueLinx in Q4 2013 and has held it in 30 quarters since.
  • Citadel Advisors's BlueLinx position peaked at $8.18M in Q4 2023.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.